- Home
- BCRX vs EXK Comparison
BCRX vs EXK Comparison
Compare BCRX & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | EXK |
|---|---|---|
| Founded | 1986 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.8B |
| IPO Year | 1995 | 2004 |
Fundamental Metrics
Financial Performance| Metric | BCRX | EXK |
|---|---|---|
| Price | $8.37 | $7.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $20.82 | $13.94 |
| AVG Volume (30 Days) | 4.4M | ★ 6.6M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | $69.59 |
| Revenue Next Year | $12.55 | $17.61 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $4.61 |
| 52 Week High | $11.22 | $15.15 |
Technical Indicators
Market Signals| Indicator | BCRX | EXK |
|---|---|---|
| Relative Strength Index (RSI) | 42.68 | 34.54 |
| Support Level | $8.13 | $7.06 |
| Resistance Level | $8.68 | $8.36 |
| Average True Range (ATR) | 0.33 | 0.53 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 25.21 | 0.46 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has three operating mining segments namely; Guanacevi and Terronera in Mexico, and Minera Kolpa in Peru. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.